5G-HEART webinar series Webinar #1 – Healthcare vertical trials

5G-HEART webinar series

Webinar #1 – Healthcare vertical trials

Towards a hospital without walls – early learnings from exploring e-health use cases

Date: 12 October 2020

Time: 09:30 – 10:40, CEST

Venue: Online


5G-HEART is one of the projects in H2020/5G PPP Phase 3, exploring 5G trials in real life scenarios with selected verticals. 5G-HEART is addressing healthcare, transport and aquaculture trials. The project has been running since June 2019, and is now able to present the first concepts and results.

This first webinar, in a series, focusses on the healthcare use cases being explored by 5G-HEART.


Draft programme:


Welcome and Introduction. What are 5G-HEART healthcare experiments, and why do we do this?

Per H Lehne, Senior researcher, Telenor

The World Health Organization (WHO) defined e-health as “… the use of information and communication technologies (ICT) for health” and e-health is identified as a priority in the European Digital Agenda. In this introduction, we will explain how 5G-HEART is working to define and implement realistic trials of 5G technology together with healthcare professionals.


5G Heart Experiences with wearable video in pilots with Oslo Ambulance Service and AmbulanceZorg Groningen.

Donal Morris, CEO and founder, RedZinc Services Limited

BlueEye Handsfree is a wearable video solution for paramedic and nurses. With wearable video, a video camera is worn on an ergonomically designed headset. This camera sends live point of view video to a remote doctor. The doctor could be in a helpdesk, different part of the hospital, or at home at night. Real time video of emergencies can benefit both patients and first responders. When the video is relayed to the emergency doctor at the hospital, the doctor can help with diagnosis, treatment and oversight before the patient reaches a hospital. Using point of view video from the paramedic to ‘immerse’ the hospital-bound doctor in the remote scene allows for quicker delivery treatment in cases where senior medical support is required. We describe the 5G-HEART approach to wearable video pilots with Oslo Ambulance Service and AmbulanceZorg Groningen and talk about the preliminary pilots conducted.

Robotic ultrasound examination over 5G network. Challenges and benefits.

MohammadReza Sajadi and Håvard Solvin, Researchers, Oslo University Hospital

In this presentation, challenges, and benefits of developing a long-distance robotic teleportation system, to capture ultrasound images over 5G network will be investigated. The presentation is divided into three main sections. In the first section, Clinical needs for having such systems in healthcare in term of medical requirements and clinical benefits will be described. Moreover, based on the clinical needs, a scenario to develop the robotic system which is compatible with the clinical needs will be proposed. In the second section, Technical aspects of the proposed scenario in term of hardware and software architectures will be presented. In addition, the advantages of developing the system on 5G networks and how 5G technology can be beneficial for the system will be discussed. Finally, the concept of robotic telepresence for the system will be investigated based on three experimental ultrasound examinations.


What’s in it for us? Whose problems are 5G empowered solutions addressing in the case of congenital heart disease?

Ewout Brandsma, Senior researcher/product developer, Philips Research; and
Hanne-Stine Hallingby, Senior research scientist, Telenor

In this presentation we go deeper into the analysis of use-case stakeholders’ points, and how these are addressed by a 5G empowered solution in the case of congenital heart disease. We elaborate on benefits that can be achieved by involving stakeholders, and on how the use case functionality and usability continuously is tested. Together, this forms the foundation for a business opportunity where some stakeholders are users, others are willing to pay the bill, and yet others engage in regulatory issues.


Questions and Answer. Closing